Break it Down: Orthocell’s Striate+ gets green light in Lion City

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, Tylah Tully gives the skinny on Orthocell (ASX:OCC) latest advancement for Striate+, landing market entry into Singapore through its distribution partner BioHorizons.

Tune in to get the latest.

Related Topics

Explore more

Explore more

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Read The Guide